Whiterabbit.ai
Develops AI software for early detection of breast cancer.
Company facts
- Founded
- 2017
- Employees
- 61
- Headquarters
- United States
- CEO
- Alexander Sardiña, MD
- Type
- Private
- Funding
- Series C · $19.5M · 2024
About
Whiterabbit.ai is an innovative AI startup committed to transforming breast cancer diagnosis through advanced technology. Founded in 2017, the company is dedicated to making late-stage breast cancer a rarity by enhancing early detection methods using artificial intelligence. Whiterabbit's flagship products, WRDensity and WRRisk, harness the power of AI to provide radiologists with essential tools for breast density assessment and cancer risk evaluation, respectively. The WRDensity software supports consistent and accurate interpretation of breast density, contributing to improved diagnostic precision. It has demonstrated to be 43% more consistent than traditional assessments by radiologists and leverages a training data set of over 600,000 images. WRRisk complements this by offering clinical decision support for breast cancer risk assessment, integrating seamlessly with existing PACS systems to deliver real-time feedback and risk scores. With a firm grasp on clinical operations cultivated through direct engagement with outpatient radiology sites, Whiterabbit approaches its mission with deep understanding and commitment.
Open positions
Research Scientist Intern (2026)
We are looking for a Research Scientist Intern to push the state of the art of our AI models. As a Research Scientist Intern at Whiterabbit.ai, you will: - Play a key role in architecting the algorithms and models that…